speb/financial-data huggingface dataset:
Financial ratios for 1334.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 47593150.68493151
Buffett classification: The Gruesome
Stock price: 0.11469072164948454
Shares outstanding: 500000000
Book value: 53198082.19178082
P/B ratio: 1.0779591756336324
Market cap (USD): 57345360.82474227
Debt to equity: 0.29390543484418535
Current ratio: 1.7683272946859905
Quick ratio: 1.611201690821256
Buyback yield (%): 0
Retained earnings: 29587945.205479454
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1334.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 45439330.54393306
Buffett classification: The Gruesome
Stock price: 0.13630573248407646
Shares outstanding: 500000000
Book value: 48524686.19246862
P/B ratio: 1.4044988559372908
Market cap (USD): 68152866.24203824
Debt to equity: 0.5697167755991286
Current ratio: 1.7806282311252823
Quick ratio: 1.6020330087540402
Buyback yield (%): 0
Retained earnings: 22039748.953974895
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1662.T — annual report dated 2022-03-31
Total revenue: 2041796426.8152761
Gross profit: 408973938.698574
Operating income: 162350434.35502377
Net income: -230724471.39813146
Capital expenditures: 114981150.63104409
Operating cash flow: -8621537.452876577
Depreciation & amortization: 145230290.11637437
Net tangible assets: 2998164235.3712506
Owner earnings: -200475331.91280118
Return on net tangible assets (%): -6.686602740025585
Capex to operating income (%): 70.82281675921251
Buffett classification: The Good
Stock price: 3.3846910342566794
Shares outstanding: 255999402
Book value: 3300844123.9141126
P/B ratio: 0.2625022110092882
Market cap (USD): 866478880.7244714
Debt to equity: 0.00191176580124091
Current ratio: 8.990135097658571
Quick ratio: 8.408739748821363
Interest coverage ratio: 16.689132266217356
COGS to revenue (%): 79.96989644376656
SG&A to revenue (%): 11.93465521393594
Free cash flow (dilution-adjusted): -144402556.95787576
Buyback yield (%): 3.534549721378281
Retained earnings: 2545418783.8059335
Inventory turnover: 13.576626916524702
Receivables turnover: 5.283090885957844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.434743675845086
FCF margin (%): -7.07232881111022
Rule of 40 score: -7.07232881111022
Financial ratios for 1662.T — annual report dated 2023-03-31
Total revenue: 2526216216.2162166
Gross profit: 721554054.0540541
Operating income: 466118618.61861867
Net income: 510367867.8678679
Capital expenditures: 270052552.5525526
Operating cash flow: 785142642.6426427
Depreciation & amortization: 107034534.53453454
Net tangible assets: 3153618618.618619
Owner earnings: 347349849.8498498
Return on net tangible assets (%): 11.014326456570695
Capex to operating income (%): 57.93644402209802
Buffett classification: The Good
Stock price: 5.902852852852853
P/E ratio: 2.960858031163413
Shares outstanding: 255999402
Book value: 3432184684.6846848
P/B ratio: 0.4402813191164717
Market cap (USD): 1511126800.4243245
Debt to equity: 0.00111556608416618
Current ratio: 4.385852140077821
Quick ratio: 4.014801556420234
Effective tax rate (%): 18.176784940542102
Interest coverage ratio: 12417.4
COGS to revenue (%): 71.43706239672859
SG&A to revenue (%): 9.254009010615407
Free cash flow (dilution-adjusted): 513641141.1411412
Buyback yield (%): 2.1179231614129033
Retained earnings: 2725142642.642643
Inventory turnover: 10.083053691275168
Receivables turnover: 7.011272477236264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.320560395292999
FCF margin (%): 20.332429894321407
Revenue growth (%): 23.72517568543901
Rule of 40 score: 44.05760557976042
Financial ratios for 1662.T — annual report dated 2024-03-31
Total revenue: 2151763074.4849443
Gross profit: 576439513.9989434
Operating income: 364817749.6038035
Net income: 374511357.6333862
Capital expenditures: 435294506.0750132
Operating cash flow: 598019017.4326466
Depreciation & amortization: 182554146.856841
Net tangible assets: 3292624141.5742207
Owner earnings: 121770998.415214
Return on net tangible assets (%): 3.6982963490328618
Capex to operating income (%): 119.31834636547929
Buffett classification: The Gruesome
Stock price: 8.366283676703645
P/E ratio: 5.718821537837294
Shares outstanding: 255999402
Book value: 3549729265.7157955
P/B ratio: 0.603359709396489
Market cap (USD): 2141763618.1984944
Debt to equity: 0.00046505484856884015
Current ratio: 5.087442713107241
Quick ratio: 4.628597616865261
Effective tax rate (%): 17.543324028843916
Interest coverage ratio: 88.2555910543131
COGS to revenue (%): 73.21082786324314
SG&A to revenue (%): 8.74968928660204
Free cash flow (dilution-adjusted): 160611463.28578976
Buyback yield (%): 2.4581570495306524
Retained earnings: 2627086634.970946
Inventory turnover: 10.590269454432457
Receivables turnover: 7.98879627359647
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.029915025832212
FCF margin (%): 7.464179731973254
Revenue growth (%): -14.822687754420743
Rule of 40 score: -7.358508022447489
Financial ratios for 1662.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 3531923238.548816
Buffett classification: The Gruesome
Stock price: 6.89753466872111
Shares outstanding: 255999402
Book value: 3806009244.9922953
P/B ratio: 0.4639412667717907
Market cap (USD): 1765764750.4668722
Debt to equity: 0.03344178189326159
Current ratio: 3.0188221916332516
Quick ratio: 2.6865910587108743
Buyback yield (%): 0
Retained earnings: 2745027314.749965
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1662.T — annual report dated 2025-03-31
Total revenue: 2600467851.8914585
Gross profit: 662725571.4476674
Operating income: 414469990.64296216
Net income: 553722764.3363186
Capital expenditures: 604651784.5207859
Operating cash flow: 873987434.834915
Depreciation & amortization: 333551664.2160139
Net tangible assets: 3493162678.786258
Owner earnings: 282622644.0315466
Return on net tangible assets (%): 8.090738108130346
Capex to operating income (%): 145.8855401286827
Buffett classification: The Gruesome
Stock price: 7.527670097580537
P/E ratio: 3.48022362010646
Shares outstanding: 255999402
Book value: 3724461970.3248224
P/B ratio: 0.5174113895612773
Market cap (USD): 1927079043.4338992
Debt to equity: 0
Current ratio: 4.6964111328125
Quick ratio: 4.335042317708333
Effective tax rate (%): 23.722540372327693
Interest coverage ratio: 23.43650793650794
COGS to revenue (%): 74.51488375201114
SG&A to revenue (%): 8.731321418107237
Free cash flow (dilution-adjusted): 266802566.50180456
Buyback yield (%): 3.825136677691133
Retained earnings: 2977536425.6115494
Inventory turnover: 16.322711406373156
Receivables turnover: 8.956561773439839
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.805264006729427
FCF margin (%): 10.259790995214376
Revenue growth (%): 20.85288955494871
Rule of 40 score: 31.112680550163084
Financial ratios for 1662.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 3493162678.786258
Buffett classification: The Gruesome
Stock price: 7.527670097580537
Shares outstanding: 255999402
Book value: 3724461970.3248224
P/B ratio: 0.5174113895612773
Market cap (USD): 1927079043.4338992
Debt to equity: 0
Current ratio: 4.6964111328125
Quick ratio: 4.335042317708333
Buyback yield (%): 0
Retained earnings: 2977536425.6115494
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1662.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.801549958483255
Shares outstanding: 255999402
Market cap (USD): 1741192722.0448382
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1662.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 3607308209.9596233
Buffett classification: The Gruesome
Stock price: 8.56749663526245
Shares outstanding: 255999402
Book value: 3840033647.3755054
P/B ratio: 0.5711601034441992
Market cap (USD): 2193274015.2641997
Debt to equity: 0
Current ratio: 6.620531906644957
Quick ratio: 6.099894032203872
Buyback yield (%): 0
Retained earnings: 3128216689.0982504
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1662.T — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.893468367412346
Shares outstanding: 255999402
Market cap (USD): 2532721985.763477
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1966.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.22820512820512823
Shares outstanding: 4222986126
Market cap (USD): 963707090.2923077
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1966.HK — annual report dated 2022-12-31
Total revenue: 3836941379.3103447
Gross profit: 635105316.091954
Operating income: 209025431.03448275
Net income: 3526436.7816091953
Capital expenditures: 17346408.04597701
Operating cash flow: 2360517816.091954
Depreciation & amortization: 18608189.655172415
Net tangible assets: 2831614367.816092
Owner earnings: 4788218.3908046
Return on net tangible assets (%): 0.16909853422228383
Capex to operating income (%): 8.298706985139711
Buffett classification: The Great
Stock price: 0.1258023106546855
P/E ratio: 150.6510524402629
Shares outstanding: 4222986126
Book value: 5262247270.114941
P/B ratio: 0.10095713584775631
Market cap (USD): 531261412.5134789
Debt to equity: 1.2061320497522465
Current ratio: 1.0770925876642907
Quick ratio: 0.28845494996805077
Effective tax rate (%): 124.49171861347183
Interest coverage ratio: 1.579393219588242
COGS to revenue (%): 83.44761482370866
SG&A to revenue (%): 11.31049366128852
Free cash flow (dilution-adjusted): 2341581465.5172415
Buyback yield (%): 0
Inventory turnover: 0.22852493205071653
Receivables turnover: 57.26409778063686
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.06905308605091
FCF margin (%): 61.027293201391565
Rule of 40 score: 61.027293201391565
Financial ratios for 1966.HK — annual report dated 2023-12-31
Total revenue: 2948096765.1195498
Gross profit: 370041068.9170183
Operating income: 21387341.7721519
Net income: -1123917018.2841067
Capital expenditures: 6936427.566807313
Operating cash flow: 716468635.7243319
Depreciation & amortization: 14449929.676511955
Net tangible assets: 1367266244.7257383
Owner earnings: -1116403516.174402
Return on net tangible assets (%): -81.65224004329478
Capex to operating income (%): 32.43239688552188
Buffett classification: The Good
Stock price: 0.021766965428937263
Shares outstanding: 4222986126
Book value: 2880777215.1898727
P/B ratio: 0.03190860873476643
Market cap (USD): 91921593.01152371
Debt to equity: 1.7537972005718496
Current ratio: 0.9021509903445534
Quick ratio: 0.2179020385545179
Interest coverage ratio: 0.10189614585922942
COGS to revenue (%): 87.44813693718724
SG&A to revenue (%): 11.987041819824352
Free cash flow (dilution-adjusted): 706257383.9662447
Buyback yield (%): 0
Inventory turnover: 0.20366371616480697
Receivables turnover: 105.68732919881006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4182537230437191
FCF margin (%): 23.956384075391938
Revenue growth (%): -23.16544680571994
Rule of 40 score: 0.7909372696719963
Financial ratios for 1966.HK — annual report dated 2024-12-31
Total revenue: 5584941780.821918
Gross profit: 854183150.6849315
Operating income: 593164657.5342466
Net income: -1077171095.890411
Capital expenditures: 5543972.602739726
Operating cash flow: -68316986.30136986
Depreciation & amortization: 8272054.794520549
Net tangible assets: 232014931.50684932
Owner earnings: -1074443013.69863
Return on net tangible assets (%): -463.0921840764854
Capex to operating income (%): 0.9346431100237362
Buffett classification: The Great
Stock price: 0.020618556701030927
Shares outstanding: 4222986126
Book value: 1447927808.2191772
P/B ratio: 0.06013551117143653
Market cap (USD): 87071878.88659793
Debt to equity: 3.3515668542091297
Current ratio: 0.8687130789891688
Quick ratio: 0.20368689429238054
Interest coverage ratio: 2.2866710286661522
COGS to revenue (%): 84.70560331321441
SG&A to revenue (%): 4.7266604243431
Free cash flow (dilution-adjusted): -74183424.65753424
Buyback yield (%): 0
Inventory turnover: 0.499236548900632
Receivables turnover: 144.6208896456316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.843421524461526
FCF margin (%): -1.3282757022154117
Revenue growth (%): 89.44228177650878
Rule of 40 score: 88.11400607429337
Financial ratios for 1966.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 232014931.50684932
Buffett classification: The Gruesome
Stock price: 0.020618556701030927
Shares outstanding: 4222986126
Book value: 1447927808.2191772
P/B ratio: 0.06013551117143653
Market cap (USD): 87071878.88659793
Debt to equity: 3.3515668542091297
Current ratio: 0.8687130789891688
Quick ratio: 0.20368689429238054
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1966.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -200877126.9177127
Buffett classification: The Gruesome
Stock price: 0.014012738853503185
Shares outstanding: 4222986126
Book value: 975892050.2092037
P/B ratio: 0.06063744627586578
Market cap (USD): 59175601.7656051
Debt to equity: 4.94091033687164
Current ratio: 0.8142671723244804
Quick ratio: 0.2085867602733207
Buyback yield (%): 0
Retained earnings: 288374337.51743376
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 205A.T — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 10943447.77402924
Buffett classification: The Gruesome
Stock price: 14.122841833697162
Shares outstanding: 3923855
Book value: 18334259.44301118
P/B ratio: 3.0225373277613214
Market cap (USD): 55415983.543361776
Debt to equity: 1.8600896958063784
Current ratio: 1.107142853543673
Quick ratio: 0.48761756034007464
Buyback yield (%): 0
Retained earnings: 8202831.249586559
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 205A.T — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 2944874.1132285437
Buffett classification: The Gruesome
Stock price: 6.777437752121297
Shares outstanding: 3923855
Book value: 23693100.570315763
P/B ratio: 1.1224230839659788
Market cap (USD): 26593683.01084991
Debt to equity: 2.2374676876669186
Current ratio: 1.1210643399680063
Quick ratio: 0.630958623521673
Buyback yield (%): 0
Retained earnings: 13030567.53373209
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 205A.T — annual report dated 2025-05-31
Total revenue: 252255605.78661844
Gross profit: 43870107.10808179
Operating income: 3388969.2585895117
Net income: 1389845.597440534
Capital expenditures: 3277117.818889971
Operating cash flow: 13873473.362080958
Depreciation & amortization: 1912748.6437613019
Net tangible assets: 2944874.1132285437
Owner earnings: 25476.422311864793
Return on net tangible assets (%): 0.8651107426773605
Capex to operating income (%): 96.69954398624161
Buffett classification: The Gruesome
Stock price: 6.777437752121297
P/E ratio: 19.134271504563834
Shares outstanding: 3923855
Book value: 23693100.570315763
P/B ratio: 1.1224230839659788
Market cap (USD): 26593683.01084991
Debt to equity: 2.2374676876669186
Current ratio: 1.1210643399680063
Quick ratio: 0.630958623521673
Effective tax rate (%): 49.03064542869166
Interest coverage ratio: 6.207605579973247
COGS to revenue (%): 82.60886731484919
Free cash flow (dilution-adjusted): 10348845.458339129
Buyback yield (%): 0
Retained earnings: 13030567.53373209
Inventory turnover: 4.775317096245974
Receivables turnover: 100.6653168505895
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.856006460924985
FCF margin (%): 4.102523480526001
Revenue growth (%): 24.836959304552543
Rule of 40 score: 28.939482785078546
Financial ratios for 205A.T — quarterly report dated 2025-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.978813270658765
Shares outstanding: 3923855
Market cap (USD): 35231561.34614075
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 20MICRONS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Depreciation & amortization: 1802967.1633917976
Buffett classification: The Gruesome
Stock price: 0.951734142160095
Shares outstanding: 35286502
Market cap (USD): 33583368.71080048
Buyback yield (%): 0
Retained earnings: 24579678.227614403
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 20MICRONS.NS — annual report dated 2023-03-31
Total revenue: 85353982.94762485
Gross profit: 30918148.599269185
Operating income: 8840609.013398295
Net income: 5111047.503045067
Capital expenditures: 1395359.317904994
Operating cash flow: 7697527.405602924
Depreciation & amortization: 1456394.6406820952
Net tangible assets: 35529561.51035323
Owner earnings: 5172082.825822169
Return on net tangible assets (%): 14.557125407570922
Capex to operating income (%): 15.783520295833368
Buffett classification: The Great
Stock price: 0.8844092570036541
P/E ratio: 6.105932100510704
Shares outstanding: 35286502
Book value: 35886857.490864806
P/B ratio: 0.869613869757809
Market cap (USD): 31207709.016077954
Debt to equity: 0.3659803734229007
Current ratio: 1.5263009455657204
Quick ratio: 0.8852515556386266
Effective tax rate (%): 26.63063623838132
Interest coverage ratio: 7.43045218619793
COGS to revenue (%): 63.776560235927995
SG&A to revenue (%): 16.697233645596
Free cash flow (dilution-adjusted): 6176492.082825823
Buyback yield (%): 0
Retained earnings: 27770779.53714982
Inventory turnover: 3.878202163339509
Receivables turnover: 7.18965437639085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.08977830880558
FCF margin (%): 7.23632555801861
Rule of 40 score: 7.23632555801861
Financial ratios for 20MICRONS.NS — annual report dated 2024-03-31
Total revenue: 93054371.02770117
Gross profit: 33226705.84002878
Operating income: 11027845.065355558
Net income: 6734656.433625135
Capital expenditures: 2352932.0062357597
Operating cash flow: 6528768.437462525
Depreciation & amortization: 1720733.900947356
Net tangible assets: 42151948.67490107
Owner earnings: 6102458.328336731
Return on net tangible assets (%): 14.47728638930132
Capex to operating income (%): 21.336280953271597
Buffett classification: The Great
Stock price: 1.6960172744721689
P/E ratio: 8.886350408150298
Shares outstanding: 35286502
Book value: 42462849.26250151
P/B ratio: 1.409385332993812
Market cap (USD): 59846516.94769674
Debt to equity: 0.3441276235344086
Current ratio: 1.7511633452851012
Quick ratio: 1.1558851026381822
Effective tax rate (%): 27.050109826732253
Interest coverage ratio: 10.139275397472932
COGS to revenue (%): 64.29323472603173
SG&A to revenue (%): 14.924784182693273
Free cash flow (dilution-adjusted): 4144561.698045329
Buyback yield (%): 0
Retained earnings: 33742295.239237316
Inventory turnover: 4.421769087325222
Receivables turnover: 6.182076305956773
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.975463594383925
FCF margin (%): 4.453914042158797
Revenue growth (%): 9.021709138988225
Rule of 40 score: 13.475623181147022
Financial ratios for 20MICRONS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 45667236.02484472
Buffett classification: The Gruesome
Stock price: 3.5425226946966077
Shares outstanding: 35286502
Book value: 45971404.682274245
P/B ratio: 2.719151938371295
Market cap (USD): 125003234.15145724
Debt to equity: 0.3413758215056099
Current ratio: 1.752286254189928
Quick ratio: 1.0440938081347644
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 20MICRONS.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.715817694369973
Shares outstanding: 35286502
Market cap (USD): 95831706.50402144
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 20MICRONS.NS — quarterly report dated 2025-03-31
Total revenue: 26584662.14636427
Gross profit: 11504863.221884498
Operating income: 2808639.233107318
Net income: 1779296.2356792144
Capital expenditures: 0
Net tangible assets: 50029705.40098199
Owner earnings: 1779296.2356792144
Return on net tangible assets (%): 3.5564795383430137
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.205858326525849
P/E ratio: 10.936490322669364
Shares outstanding: 35286502
Book value: 50742868.833294354
P/B ratio: 1.5339500118999807
Market cap (USD): 77837024.25067103
Debt to equity: 0.37973618520254954
Current ratio: 1.7014392622572578
Quick ratio: 0.9729073608296688
Effective tax rate (%): 20.29258886653253
Interest coverage ratio: 5.039561177186248
COGS to revenue (%): 56.7236809008765
Buyback yield (%): 0
Retained earnings: 39638601.82370821
Inventory turnover: 0.8073542297774328
Receivables turnover: 1.5877191267604847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.8515776800488215
Rule of 40 score: 0
Financial ratios for 20MICRONS.NS — annual report dated 2025-03-31
Total revenue: 106576911.38648584
Gross profit: 38245826.51391162
Operating income: 11760638.29787234
Net income: 7304734.627075052
Capital expenditures: 8804980.126256721
Operating cash flow: 3715969.137245733
Depreciation & amortization: 2134486.7898059385
Net tangible assets: 50029705.40098199
Owner earnings: 634241.2906242702
Return on net tangible assets (%): 1.2677294130375214
Capex to operating income (%): 74.86821636075366
Buffett classification: The Good
Stock price: 2.205858326525849
P/E ratio: 10.65569500118013
Shares outstanding: 35286502
Book value: 50742868.833294354
P/B ratio: 1.5339500118999807
Market cap (USD): 77837024.25067103
Debt to equity: 0.37973618520254954
Current ratio: 1.7014392622572578
Quick ratio: 0.9729073608296688
Effective tax rate (%): 24.442154981335634
Interest coverage ratio: 8.883752351180227
COGS to revenue (%): 64.1143414494171
SG&A to revenue (%): 15.953587465662872
Free cash flow (dilution-adjusted): -5248258.124853869
Buyback yield (%): 0
Retained earnings: 39638601.82370821
Inventory turnover: 3.6583637934056026
Receivables turnover: 6.365106306326434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.31505135886017
FCF margin (%): -4.9243856446747785
Revenue growth (%): 14.531870141553242
Rule of 40 score: 9.607484496878463
Financial ratios for 20MICRONS.NS — quarterly report dated 2025-06-30
Total revenue: 28921706.06131524
Gross profit: 13142756.845307747
Operating income: 3130599.110695062
Net income: 1973367.6573835714
Capital expenditures: 0
Owner earnings: 1973367.6573835714
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.6777439737889073
P/E ratio: 25.178971732923415
Shares outstanding: 35286502
Market cap (USD): 94488218.08659023
Effective tax rate (%): 26.25908403221716
Interest coverage ratio: 5.696361274937722
COGS to revenue (%): 54.55746345860597
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 8.790948337368967
Rule of 40 score: 8.790948337368967
Financial ratios for 20MICRONS.NS — quarterly report dated 2025-09-30
Total revenue: 26018365.27621195
Gross profit: 11767068.77113867
Operating income: 2975456.5952649377
Net income: 1961104.8478015782
Capital expenditures: 0
Net tangible assets: 51140236.753100336
Owner earnings: 1961104.8478015782
Return on net tangible assets (%): 3.8347590318550644
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.3213077790304397
P/E ratio: 14.335692482888605
Shares outstanding: 35286502
Book value: 51681397.97068772
P/B ratio: 1.5849190386419263
Market cap (USD): 81910831.58737317
Debt to equity: 0.356371751299044
Current ratio: 1.7821068334529941
Quick ratio: 1.0703438391543696
Effective tax rate (%): 26.02734469924668
Interest coverage ratio: 5.937124603513823
COGS to revenue (%): 54.77398888739157
Buyback yield (%): 0
Inventory turnover: 0.7999395025540553
Receivables turnover: 1.5715317850192236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.077941240699028
Revenue growth (%): -10.038622130202425
Rule of 40 score: -10.038622130202425
Financial ratios for 20MICRONS.NS — quarterly report dated 2025-12-31
Total revenue: 23930199.39846274
Gross profit: 10942887.37885708
Operating income: 2542129.887490253
Net income: 1666046.5634399022
Capital expenditures: 0
Owner earnings: 1666046.5634399022
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.3556867550406597
P/E ratio: 11.263689125747337
Shares outstanding: 35286502
Market cap (USD): 83123945.39311574
Effective tax rate (%): 25.400632181024534
Interest coverage ratio: 5.595503138485681
COGS to revenue (%): 54.27164146588748
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.025738187550079
Rule of 40 score: -8.025738187550079
Financial ratios for 2391.T — annual report dated 2021-07-31
Total revenue: 28032090.302531764
Gross profit: 18315812.082990587
Operating income: 6446650.214788411
Net income: 4552408.372178046
Capital expenditures: 6480.212046430856
Operating cash flow: 7128662.827895074
Depreciation & amortization: 2054876.1539164612
Net tangible assets: 39851466.9591445
Owner earnings: 6600804.314048077
Return on net tangible assets (%): 16.563516522027115
Capex to operating income (%): 0.1005206088514847
Buffett classification: The Great
Stock price: 11.960789690156295
P/E ratio: 17.421382039997674
Shares outstanding: 6630770
Book value: 44173475.91627823
P/B ratio: 1.7954042286396497
Market cap (USD): 79309245.45379765
Debt to equity: 0
Current ratio: 6.051818341112191
Quick ratio: 6.051818341112191
Effective tax rate (%): 31.054052969113577
COGS to revenue (%): 34.66130158190877
SG&A to revenue (%): 5.052476515255506
Free cash flow (dilution-adjusted): 5481217.4389909515
Buyback yield (%): 0
Retained earnings: 25719532.03546294
Receivables turnover: 6.276200708044283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.264385588825633
FCF margin (%): 19.55336680153284
Rule of 40 score: 19.55336680153284
Financial ratios for 2391.T — annual report dated 2022-07-31
Total revenue: 23295729.166666664
Gross profit: 15442440.476190476
Operating income: 5249077.380952381
Net income: 3914553.5714285714
Capital expenditures: 0
Operating cash flow: 5126830.357142857
Depreciation & amortization: 1423139.8809523808
Net tangible assets: 34130721.72619048
Owner earnings: 5337693.452380952
Return on net tangible assets (%): 15.638970354046252
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.055059523809522
P/E ratio: 13.644275410745918
Shares outstanding: 6630770
Book value: 38402291.666666664
P/B ratio: 1.3908348882483914
Market cap (USD): 53411247.03869046
Debt to equity: 0
Current ratio: 5.749539347578373
Quick ratio: 5.749539347578373
Effective tax rate (%): 30.677706596815042
COGS to revenue (%): 33.71128087165987
SG&A to revenue (%): 5.740341736970233
Free cash flow (dilution-adjusted): 3483616.0714285714
Buyback yield (%): 6.965270989728435e-05
Retained earnings: 22482090.773809522
Receivables turnover: 6.1744981531404495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.36005982787834
FCF margin (%): 14.95388294783749
Revenue growth (%): -16.8962110379522
Rule of 40 score: -1.9423280901147084
Financial ratios for 2391.T — annual report dated 2023-07-31
Total revenue: 22249531.116794545
Gross profit: 14469082.125603866
Operating income: 4445389.315146348
Net income: 3143101.7334470022
Capital expenditures: 14236.999147485081
Operating cash flow: 4491467.746518898
Depreciation & amortization: 1484960.2159704464
Net tangible assets: 32871184.995737426
Owner earnings: 4613824.950269964
Return on net tangible assets (%): 14.036077345152789
Capex to operating income (%): 0.320264393918812
Buffett classification: The Great
Stock price: 8.392014776925263
P/E ratio: 17.704014868576
Shares outstanding: 6630770
Book value: 37975532.82182438
P/B ratio: 1.465299251585839
Market cap (USD): 55645519.82239273
Debt to equity: 0
Current ratio: 7.043168334665482
Quick ratio: 7.043168334665482
Effective tax rate (%): 32.52666607696789
COGS to revenue (%): 34.96904698956909
SG&A to revenue (%): 6.298717305204218
Free cash flow (dilution-adjusted): 1483034.9531116795
Buyback yield (%): 0
Retained earnings: 22346689.40039784
Receivables turnover: 6.267925117379348
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.564856558864777
FCF margin (%): 6.665466096012445
Revenue growth (%): -4.490943564750488
Rule of 40 score: 2.1745225312619576
Financial ratios for 2391.T — annual report dated 2024-07-31
Total revenue: 20780441.475076966
Gross profit: 13229259.186480645
Operating income: 4207146.13218052
Net income: 3000596.056854654
Capital expenditures: 12543.394249033865
Operating cash flow: 4096986.9653501017
Depreciation & amortization: 1384116.0673347744
Net tangible assets: 29195853.80231873
Owner earnings: 4372168.729940395
Return on net tangible assets (%): 14.97530697181789
Capex to operating income (%): 0.29814496228427306
Buffett classification: The Great
Stock price: 8.255649439968561
P/E ratio: 18.243479495351465
Shares outstanding: 6630770
Book value: 35540911.770485364
P/B ratio: 1.540233773139151
Market cap (USD): 54741312.63706034
Debt to equity: 0
Current ratio: 5.565143288788402
Quick ratio: 5.565143288788402
Effective tax rate (%): 33.70760501337856
COGS to revenue (%): 36.337930056263886
SG&A to revenue (%): 5.473199791965453
Free cash flow (dilution-adjusted): 2091681.40433615
Buyback yield (%): 0.0013640677418524747
Retained earnings: 28482943.603851445
Receivables turnover: 6.125926598170651
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.744787112511917
FCF margin (%): 10.065625443255426
Revenue growth (%): -6.602789218369959
Rule of 40 score: 3.462836224885467
Financial ratios for 2391.T — quarterly report dated 2025-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.885528877352369
Shares outstanding: 6630770
Market cap (USD): 52287128.31408177
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2391.T — annual report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.32305836628024
Shares outstanding: 6630770
Market cap (USD): 55188285.72338002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2391.T — quarterly report dated 2025-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.923651721897336
Shares outstanding: 6630770
Market cap (USD): 52539912.1280052
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2487.HK — annual report dated 2023-12-31
Total revenue: 19356258.790436003
Gross profit: 9987060.478199719
Operating income: -74117018.2841069
Net income: -276196624.4725738
Capital expenditures: 7837130.801687763
Operating cash flow: -53630379.74683544
Depreciation & amortization: 5975246.132208157
Net tangible assets: 188629676.511955
Owner earnings: -278058509.1420534
Return on net tangible assets (%): -147.4097365185433
Buffett classification: The Gruesome
Stock price: 1.4058898847631243
Shares outstanding: 363368277
Book value: 189738255.97749647
P/B ratio: 2.692423741571094
Market cap (USD): 510855785.07810503
Debt to equity: 0.18068788226285526
Current ratio: 5.558801827401605
Quick ratio: 5.380952007158893
Interest coverage ratio: -117.70649988831809
COGS to revenue (%): 48.40397317308881
R&D to revenue (%): 156.74051575681392
SG&A to revenue (%): 185.40796233187768
Free cash flow (dilution-adjusted): -80109142.05344585
Buyback yield (%): 0
Retained earnings: -414890295.3586498
Inventory turnover: 1.4700754733636405
Receivables turnover: 2.2126595710473005
Capitalized R&D asset: 47739461.928318545
ROCI (R&D-adjusted, %): -24.824501605401732
Rosenberg metric: 0.34063566868192496
FCF margin (%): -413.8668681833705
Revenue growth (%): 1085.285598992034
Rule of 40 score: 671.4187308086634
Financial ratios for 2487.HK — annual report dated 2024-12-31
Total revenue: 38303424.65753425
Gross profit: 19652465.75342466
Operating income: -62348904.10958904
Net income: -59426164.38356165
Capital expenditures: 3090273.97260274
Operating cash flow: -60682739.7260274
Depreciation & amortization: 6104383.561643836
Net tangible assets: 132247260.2739726
Owner earnings: -56412054.79452055
Return on net tangible assets (%): -42.656501675462636
Buffett classification: The Gruesome
Stock price: 0.8711340206185567
Shares outstanding: 363368277
Book value: 133524657.53424658
P/B ratio: 2.3706667663765413
Market cap (USD): 316542468.1082474
Debt to equity: 0.32925938465010823
Current ratio: 3.363086270421437
Quick ratio: 3.132021246647342
Interest coverage ratio: -41.91040515653775
COGS to revenue (%): 48.692666702430124
R&D to revenue (%): 71.18537989735887
SG&A to revenue (%): 107.10977594192013
Free cash flow (dilution-adjusted): -73599452.05479452
Buyback yield (%): 0.5996728304503716
Retained earnings: -463517945.20547944
Inventory turnover: 1.8228458201681574
Receivables turnover: 2.8197228833044248
Capitalized R&D asset: 56163962.84813781
ROCI (R&D-adjusted, %): -31.045599945077022
Rosenberg metric: 0.3185791707740882
FCF margin (%): -192.14848988788154
Revenue growth (%): 97.88650829808138
Rule of 40 score: -94.26198158980016
Financial ratios for 2487.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 132247260.2739726
Buffett classification: The Gruesome
Stock price: 0.8711340206185567
Shares outstanding: 363368277
Book value: 133524657.53424658
P/B ratio: 2.3706667663765413
Market cap (USD): 316542468.1082474
Debt to equity: 0.32925938465010823
Current ratio: 3.363086270421437
Quick ratio: 3.132021246647342
Buyback yield (%): 0
Retained earnings: -463517945.20547944
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2487.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 104271687.58716875
Buffett classification: The Gruesome
Stock price: 1.2764331210191082
Shares outstanding: 363368277
Book value: 105525801.9525802
P/B ratio: 4.395278645680126
Market cap (USD): 463815303.8904458
Debt to equity: 0.38381882583066795
Current ratio: 3.1634885348799644
Quick ratio: 2.9202787627977815
Buyback yield (%): 0
Retained earnings: -505309344.49093443
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2563.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 106546196.50410959
Buffett classification: The Gruesome
Stock price: 2.448453608247423
Shares outstanding: 216720857
Book value: 108321596.15068494
P/B ratio: 4.898662715105943
Market cap (USD): 530630964.30412376
Debt to equity: 0.001494455161720095
Current ratio: 8.833368389102834
Quick ratio: 8.436466753815512
Buyback yield (%): 0
Retained earnings: -119468264.98082192
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2563.HK — annual report dated 2024-12-31
Total revenue: 9844596.104109589
Gross profit: 8509645.421917807
Operating income: -19565263.952054795
Net income: -19695413.471232876
Capital expenditures: 5589661.308219178
Operating cash flow: -15423126.816438356
Depreciation & amortization: 1343224.1753424658
Net tangible assets: 106546196.50410959
Owner earnings: -23941850.604109585
Return on net tangible assets (%): -22.47086370951414
Buffett classification: The Gruesome
Stock price: 2.448453608247423
Shares outstanding: 216720857
Book value: 108321596.15068494
P/B ratio: 4.898662715105943
Market cap (USD): 530630964.30412376
Debt to equity: 0.001494455161720095
Current ratio: 8.833368389102834
Quick ratio: 8.436466753815512
Interest coverage ratio: -2568.5642323473103
COGS to revenue (%): 13.560238206568078
R&D to revenue (%): 161.81844489554769
SG&A to revenue (%): 58.21059840481937
Free cash flow (dilution-adjusted): -22253884.015068494
Buyback yield (%): 0
Retained earnings: -119468264.98082192
Inventory turnover: 0.31016541057208746
Receivables turnover: 3.1040414720980163
Capitalized R&D asset: 30773565.832757324
ROCI (R&D-adjusted, %): -12.291136449500508
Rosenberg metric: 0.10809944087370187
FCF margin (%): -226.051772766774
Revenue growth (%): 5.042512643834586
Rule of 40 score: -221.00926012293942
Financial ratios for 2869.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7576923076923078
Shares outstanding: 3120750476
Market cap (USD): 2364568629.8923078
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2869.HK — annual report dated 2022-12-31
Total revenue: 2134532040.229885
Gross profit: 345108189.6551724
Operating income: 152913793.10344827
Net income: 90721695.40229885
Capital expenditures: 491235.6321839081
Operating cash flow: 99895977.01149425
Depreciation & amortization: 62258908.04597701
Net tangible assets: 843082327.5862069
Owner earnings: 152489367.81609195
Return on net tangible assets (%): 18.087126586163627
Capex to operating income (%): 0.321250046980118
Buffett classification: The Great
Stock price: 0.5596919127086009
P/E ratio: 19.252933879302887
Shares outstanding: 3120750476
Book value: 1131629741.3793106
P/B ratio: 1.5434896584370121
Market cap (USD): 1746658802.9987166
Debt to equity: 0.2347595771178862
Current ratio: 1.4674291916289655
Quick ratio: 1.390242185623936
Effective tax rate (%): 26.913643408519793
Interest coverage ratio: 12.447428130336133
COGS to revenue (%): 83.83213823213424
SG&A to revenue (%): 9.565247652130811
Free cash flow (dilution-adjusted): 94235632.18390805
Buyback yield (%): 0.642268948416082
Retained earnings: 560198132.1839081
Inventory turnover: 21.841491923250274
Receivables turnover: 3.2223572552119166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.242927217606862
FCF margin (%): 4.4148146014130125
Rule of 40 score: 4.4148146014130125
Financial ratios for 2869.HK — annual report dated 2023-12-31
Total revenue: 2364562306.610408
Gross profit: 388114908.5794655
Operating income: 138904922.64416313
Net income: 100721518.98734176
Capital expenditures: 397187.0604781997
Operating cash flow: 201979184.24753866
Depreciation & amortization: 68150773.55836849
Net tangible assets: 852464838.2559775
Owner earnings: 168475105.48523206
Return on net tangible assets (%): 19.763290862519124
Capex to operating income (%): 0.2859416735688235
Buffett classification: The Great
Stock price: 0.3213828425096031
P/E ratio: 9.957709820342602
Shares outstanding: 3120750476
Book value: 1156850070.3234882
P/B ratio: 0.8669711697900678
Market cap (USD): 1002955658.7400769
Debt to equity: 0.21047052450006098
Current ratio: 1.415328848002197
Quick ratio: 1.3365924142786612
Effective tax rate (%): 26.47043720926333
Interest coverage ratio: 27.04680268382856
COGS to revenue (%): 83.58618389989363
SG&A to revenue (%): 9.097897589810348
Free cash flow (dilution-adjusted): 197236146.2728551
Buyback yield (%): 1.832936894427722
Retained earnings: 633525316.4556962
Inventory turnover: 20.855996461800355
Receivables turnover: 3.332526170836577
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.369582820251349
FCF margin (%): 8.341338509941506
Revenue growth (%): 10.776613423696789
Rule of 40 score: 19.117951933638295
Financial ratios for 2869.HK — annual report dated 2024-12-31
Total revenue: 2451160684.931507
Gross profit: 412515479.4520548
Operating income: 155451369.8630137
Net income: 118817397.26027398
Capital expenditures: 894657.5342465753
Operating cash flow: 202016575.34246576
Depreciation & amortization: 73736438.35616438
Net tangible assets: 942199315.0684931
Owner earnings: 191659178.0821918
Return on net tangible assets (%): 20.341680896706993
Capex to operating income (%): 0.5755224511916248
Buffett classification: The Great
Stock price: 0.4445876288659794
P/E ratio: 11.677137240836556
Shares outstanding: 3120750476
Book value: 1170281780.8219178
P/B ratio: 1.1855666533856302
Market cap (USD): 1387447054.4072165
Debt to equity: 0.09405520763820258
Current ratio: 1.4831989351328765
Quick ratio: 1.4130846298268795
Effective tax rate (%): 29.78784810694084
Interest coverage ratio: 29.70823079742395
COGS to revenue (%): 83.17060639932784
SG&A to revenue (%): 8.409943670521647
Free cash flow (dilution-adjusted): 198322876.71232876
Buyback yield (%): 0.7121683579004178
Retained earnings: 724581506.849315
Inventory turnover: 24.888053086985458
Receivables turnover: 3.6945177308625405
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.381244056474781
FCF margin (%): 8.09097820193989
Revenue growth (%): 3.6623428394761888
Rule of 40 score: 11.75332104141608
Financial ratios for 2869.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 942199315.0684931
Buffett classification: The Gruesome
Stock price: 0.4445876288659794
Shares outstanding: 3120750476
Book value: 1170281780.8219178
P/B ratio: 1.1855666533856302
Market cap (USD): 1387447054.4072165
Debt to equity: 0.09405520763820258
Current ratio: 1.4831989351328765
Quick ratio: 1.4130846298268795
Buyback yield (%): 0
Retained earnings: 724581506.849315
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2869.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 970272524.4072524
Buffett classification: The Gruesome
Stock price: 0.5261146496815287
Shares outstanding: 3120750476
Book value: 1179451743.3751745
P/B ratio: 1.3920641964763596
Market cap (USD): 1641872543.4242039
Debt to equity: 0.08484983863031649
Current ratio: 1.448975089152761
Quick ratio: 1.3890764642587097
Buyback yield (%): 0
Retained earnings: 823192887.0292888
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2993.T — annual report dated 2022-03-31
Total revenue: 69459850.84412391
Gross profit: 25653991.14899197
Operating income: 16517038.190460581
Net income: 12808474.020652352
Capital expenditures: 6099672.184887723
Operating cash flow: 30328765.77610228
Depreciation & amortization: 10029888.542861827
Net tangible assets: 71540968.69365679
Owner earnings: 16738690.378626458
Return on net tangible assets (%): 23.397349356985437
Capex to operating income (%): 36.92957608108329
Buffett classification: The Good
Stock price: 11.210047533191279
P/E ratio: 3.7975763897651142
Shares outstanding: 4339068
Book value: 71992640.5507294
P/B ratio: 0.6756407065729777
Market cap (USD): 48641158.529749215
Debt to equity: 4.424041344443455
Current ratio: 2.1750015011196155
Quick ratio: 2.16413217468053
Effective tax rate (%): 34.12845560185667
Interest coverage ratio: 3.8312701267199194
COGS to revenue (%): 63.06644653389403
Free cash flow (dilution-adjusted): 17121152.270119652
Buyback yield (%): 0
Retained earnings: 55425389.28044583
Inventory turnover: 120.0330331679055
Receivables turnover: 24.200269542548604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.0736024765064
FCF margin (%): 24.64899083722701
Rule of 40 score: 24.64899083722701
Financial ratios for 2993.T — annual report dated 2023-03-31
Total revenue: 68786689.1891892
Gross profit: 26581959.45945946
Operating income: 17487379.87987988
Net income: 10285810.810810812
Capital expenditures: 42335570.57057057
Operating cash flow: 15132792.792792793
Depreciation & amortization: 9871373.873873875
Net tangible assets: 70803040.54054055
Owner earnings: -22178385.885885887
Return on net tangible assets (%): -31.324058566647206
Capex to operating income (%): 242.09213079015797
Buffett classification: The Gruesome
Stock price: 13.369969969969972
P/E ratio: 5.640120154327882
Shares outstanding: 4339068
Book value: 71189429.42942947
P/B ratio: 0.8149132437585629
Market cap (USD): 58013208.85765766
Debt to equity: 4.452378145184693
Current ratio: 2.3098321408285476
Quick ratio: 2.2934582387501186
Effective tax rate (%): 31.61144535463618
Interest coverage ratio: 4.5707605575210986
COGS to revenue (%): 61.355954512726875
Free cash flow (dilution-adjusted): -27379256.75675676
Buyback yield (%): 4.535831465275073
Retained earnings: 57371403.90390391
Inventory turnover: 99.5479175520612
Receivables turnover: 28.346601614345335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.361780701312364
FCF margin (%): -39.80313208774089
Revenue growth (%): -0.9691377778011261
Rule of 40 score: -40.772269865542015
Financial ratios for 2993.T — annual report dated 2024-03-31
Total revenue: 61863417.85525621
Gross profit: 23209356.840993132
Operating income: 12045338.087691495
Net income: 8295655.044902272
Capital expenditures: 13405619.38721606
Operating cash flow: 21253374.273639727
Depreciation & amortization: 9333716.323296355
Net tangible assets: 67560598.25673534
Owner earnings: 4223751.980982566
Return on net tangible assets (%): 6.251797778539485
Capex to operating income (%): 111.29301053753373
Buffett classification: The Gruesome
Stock price: 13.218964606444798
P/E ratio: 6.914220276336591
Shares outstanding: 4339068
Book value: 67746784.20496571
P/B ratio: 0.846652531040034
Market cap (USD): 57357986.31695722
Debt to equity: 4.311684511626358
Current ratio: 2.3584554212212345
Quick ratio: 2.3489078241898924
Effective tax rate (%): 33.03570714691959
Interest coverage ratio: 3.5187797910120118
COGS to revenue (%): 62.48289498234314
Free cash flow (dilution-adjusted): -12620179.609086107
Buyback yield (%): 2.403787084258842
Retained earnings: 55705289.22345483
Inventory turnover: 135.98870975235795
Receivables turnover: 27.70102068573997
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2491393854018016
FCF margin (%): -20.400068484114374
Revenue growth (%): -10.06484163657215
Rule of 40 score: -30.464910120686525
Financial ratios for 2993.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 73093234.34654714
Buffett classification: The Gruesome
Stock price: 12.335761311107998
Shares outstanding: 4339068
Book value: 73258005.32287437
P/B ratio: 0.7306465269530575
Market cap (USD): 53525707.16066676
Debt to equity: 4.27698991317024
Current ratio: 2.735159496142998
Quick ratio: 2.719289401920048
Buyback yield (%): 0
Retained earnings: 63743647.56968763
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2993.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 79617196.89881031
Buffett classification: The Gruesome
Stock price: 13.37267744953883
Shares outstanding: 4339068
Book value: 79753863.1199038
P/B ratio: 0.7275504223335174
Market cap (USD): 58024956.795615554
Debt to equity: 4.098290564984348
Current ratio: 2.998059869782569
Quick ratio: 2.9897854857521082
Buyback yield (%): 0
Retained earnings: 66058474.80283384
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2993.T — annual report dated 2025-03-31
Total revenue: 66956342.73492848
Gross profit: 22422169.496056676
Operating income: 12035997.861248495
Net income: 13818988.10319476
Capital expenditures: 28749846.277235664
Operating cash flow: 12591752.439513434
Depreciation & amortization: 10565492.58120572
Net tangible assets: 79617196.89881031
Owner earnings: -4365365.592835184
Return on net tangible assets (%): -5.482943086257303
Capex to operating income (%): 238.865498387962
Buffett classification: The Gruesome
Stock price: 13.37267744953883
P/E ratio: 4.198929499201246
Shares outstanding: 4339068
Book value: 79753863.1199038
P/B ratio: 0.7275504223335174
Market cap (USD): 58024956.795615554
Debt to equity: 4.098290564984348
Current ratio: 2.998059869782569
Quick ratio: 2.9897854857521082
Effective tax rate (%): 30.95916346800813
Interest coverage ratio: 3.0279163535051388
COGS to revenue (%): 66.51225473167919
Free cash flow (dilution-adjusted): -33980744.55286726
Buyback yield (%): 0
Retained earnings: 66058474.80283384
Inventory turnover: 195.0986150557784
Receivables turnover: 30.17944979334112
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8786366840502393
FCF margin (%): -50.750598322540775
Revenue growth (%): 8.232530720479026
Rule of 40 score: -42.51806760206175
Financial ratios for 2993.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 78990417.22745626
Buffett classification: The Gruesome
Stock price: 14.21965006729475
Shares outstanding: 4339068
Book value: 79100558.54643339
P/B ratio: 0.7800201378094886
Market cap (USD): 61700028.5781965
Debt to equity: 4.364958892215412
Current ratio: 2.9763806932218806
Quick ratio: 2.9528473313237766
Buyback yield (%): 0
Retained earnings: 70370874.83176312
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3668.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8756410256410259
Shares outstanding: 1320439437
Market cap (USD): 2476670379.9115386
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0